Longen Zhou - Janssen Research & Development

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 12 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Efficacy, Safety, and Pharmacokinetics of Teclistamab in Chinese Patients with Relapsed/refractory Multiple Myeloma from the China Cohort of MajesTEC-1

Zhen Cai,Zhongjun Xia,Ai-Li He,Yu-Jun Dong,Yafei Wang,Aijun Liao, Yang Song, Juanjuan Song,Clarissa Uhlar,Katherine Chastain, Latisha Watkins, Xinchao Luo, Lin Huang,Zhuolu Niu, Natalia A. Quijano Carde,Yue Guo,Hongmei Xu,Raluca I. Verona,Longen Zhou, Jingyun Li,Weijun Fu,Ting Niu,Juan Du

CANCERno. 1 (2025)

Cited0Views0WOSBibtex

Identification of Fibroblast Growth Factor Receptors (fgfrs) Alterations (alts) at DNA and RNA-level by One-Step Next-Generation Sequencing (NGS) Panel

Min Qing,Xuejun Chen, Wenqing Su, Xiaofang Zhuo, Ting Shen, Chengjuan Xiong,Xuesong Lyu, Renee Tate,Qibiao Wu,Longen Zhou, Shibu Thomas, Wangwang Ning, Jianqing Wang, Huihui Yan, Zhiqiang Yin,Zhan Huang, Yaxin Xue, Changbin Zhu

CANCER RESEARCHno. 6 (2024)

Cited0Views0Bibtex

Prevalence of Fibroblast Growth Factor Receptor (FGFR) Alterations (alts) and Programmed Death-Ligand 1 (PD-L1) Expression (exp) in Chinese Solid Tumor Patients (Pts)

Min Qing,Fei Yang, Xiaowei Chen,Xuesong Lyu,Aodi Wang,Yanfei Yu, Shibu Thomas,Longen Zhou

Cancer Researchno. 6_Supplement (2024): 5099-5099

Cited0Views0Bibtex

Longitudinal High-Dimensional Analysis Identifies Biomarkers of Response to Anti-PD-1 Immunotherapy

Run-Ze Li, Xing,Zebo Jiang,Jumin Huang, Lily Yan Wang,Yue Fan,Hongmei Xu,Haopeng Rui,Longen Zhou,Paul Gavine,Yan Wang, Piu Wong,Hermi Sumatoh,Michael Fehling,Alessandra Nardin,Liang Liu,Yabing Cao,Elaine Lai-Han Leung

SSRN Electronic Journal (2021)

Cited0Views0Bibtex

High Efficacy Vasopermeability Drug Candidates Identified by Screening in an Ex Ovo Chorioallantoic Membrane Model

Desmond Pink,Keith A. Luhrs,Longen Zhou,Wendy Schulte,Jennifer Chase,Christian Frosch,Udo Haberl,Van Nguyen, Aparna I. Roy,John D. Lewis,Andries Zijlstra,Missag H. Parseghian

Scientific Reports（2015）

Cited7Views0WOSNATUREBibtex

BGB324, a Selective Small Molecule Axl Kinase Inhibitor to Overcome EMT-associated Drug Resistance in Carcinomas: Therapeutic Rationale and Early Clinical Studies

Katarzyna Wnuk-Lipinska,Crina Tiron,Gro Gausdal,Tone Sandal,Robin Frink,Stefan Hinz,Monica Hellesoy,Lavina Ahmed,Hallvard Haugen, Xiao Liang,Magnus Blo,David Micklem,Murray Yule,John Minna,Longen Zhou,Rolf Brekken,James Lorens

CANCER RESEARCH（2014）

Cited16Views0Bibtex

Abstract B30: Selective Small Molecule AXL Inhibitor BGB324 Overcomes Acquired Drug Resistance in Non-Small Cell Lung Carcinoma Models

Katarzyna Wnuk-Lipinska,Gro Gausdal,Tone Sandal,Robin Frink,Stefan Hinz,Monica Hellesoy,Lavina Ahmed,Hallvard Haugen,Liang Xiao,Magnus Blo,David Micklem,John Minna,Rolf Brekken,Longen Zhou,James Lorens

CLINICAL CANCER RESEARCH（2014）

Cited4Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn